Medicine and Dentistry
Drug Therapy
100%
Therapeutic Procedure
65%
Cohort Effect
55%
Mental Health
54%
Impulse Control Disorder
47%
Parkinson's Disease
47%
Drug
47%
COVID-19
47%
Disease
47%
Patient
44%
Association
22%
Antiparkinson Agent
20%
Dopamine Agonist
20%
Mental Health Care
15%
Monoamine Oxidase B Inhibitor
13%
Combination Therapy
13%
Mental Health Service
13%
Addictive Behavior
13%
Restless Legs Syndrome
11%
Side Effect
10%
Stress
7%
Health Care
7%
Ropinirole
7%
Serotonin-Norepinephrine Reuptake Inhibitor
7%
Tavapadon
7%
Deep Brain Stimulation
7%
Rotigotine
7%
Odds Ratio
7%
Psychiatry
6%
Clinical Feature
6%
Clinician
6%
Family Health
6%
Medical Record
6%
Prevalence
6%
Patient Experience
6%
Awareness
6%
High Risk Population
5%
Learning
5%
Antipsychotics
5%
Health
5%
Neuroscience
Dopaminergic
77%
Pramipexole
53%
Parkinson's Disease
53%
Neuroscience
47%
Pathological Gambling
47%
Impulse Control Disorder
47%
Dopamine Agonist
26%
Behavior (Neuroscience)
23%
Ropinirole
17%
Stereotypy
7%
Iowa Gambling Task
7%
Reward System
7%
Antipsychotic
5%
Aripiprazole
5%
Striatum
5%
L-DOPA
5%
Nervous System Disorder
5%
Agonist
5%
Pharmacology, Toxicology and Pharmaceutical Science
Dopamine Receptor Stimulating Agent
56%
Psychotropic Agent
47%
Impulse Control Disorder
47%
Parkinson's Disease
47%
Drug
23%
Epidemiology
23%
Deterioration
23%
Antiparkinson Agent
20%
Comorbidity
13%
Pathological Gambling
13%
Monoamine Oxidase B Inhibitor
13%
Anxiety Disorder
6%
Diseases
6%
Patient Registry
6%
Side Effect
6%
Tavapadon
5%
Serotonin-Norepinephrine Reuptake Inhibitor
5%
